Credit Suisse Ag Deciphera Pharmaceuticals, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 35,958 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,958
Previous 34,931
2.94%
Holding current value
$0
Previous $563,000
0.36%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding DCPH
# of Institutions
7Shares Held
343KCall Options Held
500Put Options Held
0-
Jefferies Group LLC New York, NY175KShares$00.03% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA81KShares$00.01% of portfolio
-
Deka Bank Deutsche Girozentrale50KShares$00.0% of portfolio
-
Cutler Group LP300Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,204Shares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...